Screener
Indivior Pharmaceuticals, Inc. INDV Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 667 | 652 |
| Long-term investments | 27 | 28 |
| Property, plant and equipment, net | 157 | 144 |
| Operating lease right of use assets, net | 22 | 26 |
| Goodwill and other intangible assets, net | 2 | 2 |
| Deferred tax assets | 296 | 323 |
| Other noncurrent assets | 26 | 27 |
| Total assets | $1,197 | $1,201 |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s operating lease ROU assets?
- Indivior Pharmaceuticals, Inc. (INDV) reported operating lease ROU assets of $22M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s operating lease ROU assets decreased by 40.5% year-over-year, from $37M to $22M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a -19.4% compound annual growth rate (CAGR), from $40M to $26M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Indivior Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude